• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.79%

    AbbVie Inc. (ABBV)

    -NYSE
    61.46 Down 0.31(0.50%) May 4, 4:04PM EDT
    |After Hours : 61.46 0.00 (0.00%) May 4, 5:25PM EDT
    Prev Close:61.77
    Open:61.30
    Bid:61.07 x 100
    Ask:61.77 x 100
    1y Target Est:70.83
    Beta:1.46764
    Earnings Date:Jul 22 - Jul 26 (Est.)
    Day's Range:61.01 - 61.65
    52wk Range:45.45 - 71.60
    Volume:8,691,399
    Avg Vol (3m):7,177,670
    Market Cap:99.43B
    P/E (ttm):19.64
    EPS (ttm):3.13
    Div & Yield:2.28 (3.74%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.50%99.43B
    PFEDown 0.89%206.81B
    MRKDown 0.49%151.81B

    Key Statistics

    Forward P/E (1 yr):10.69
    P/S (ttm):4.35
    Ex-Dividend Date:13-Apr-16

    Analysts

    Annual EPS Est (Dec-16) :4.83
    Quarterly EPS Est (Jun-16) :1.20
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the trea... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback